SEC FORM 4
$6,567,875.94
Travere Therapeutics, Inc. (TVTX)
Sale of 101,691 shares at $64.5866 per share.
Reporting Person Dube Eric M · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001763494-26-000007 · filed 2026-09-17 · View filing →